Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin.
The survival of 64 consecutive patients with disseminated midgut carcinoid tumours was compared in a retrospective study with that of 25 consecutive patients with sporadic malignant endocrine pancreatic tumours treated according to similar surgical principles. The presence of hepatic metastases implied a worse prognosis in neuroendocrine tumours of pancreatic rather than midgut origin. This infers that these tumour types must be separated when treatments are evaluated.
Johanson
V
V
Department of Surgery, Sahlgrenska University Hospital, Göteborg University, Sweden.
Tisell
L E
LE
Olbe
L
L
Wängberg
B
B
Nilsson
O
O
Ahlman
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D002276:Carcinoid Tumor / Q000473:pathology*; D018278:Carcinoma, Neuroendocrine / Q000473:pathology / Q000556:secondary; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000473:pathology*; D008113:Liver Neoplasms / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000473:pathology*; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis